FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2278884054> ?p ?o ?g. }

• W2278884054 endingPage "15126" @default.
• W2278884054 startingPage "15113" @default.
• W2278884054 abstract "Stroke is the world's leading cause of physiological disability, but there are currently no available agents that can be delivered early after stroke to enhance recovery. Daidzein, a soy isoflavone, is a clinically approved agent that has a neuroprotective effect in vitro, and it promotes axon growth in an animal model of optic nerve crush. The current study investigates the efficacy of daidzein on neuroprotection and functional recovery in a clinically relevant mouse model of stroke recovery. In light of the fact that cholesterols are essential lipid substrates in injury-induced synaptic remodeling, we found that daidzein enhanced the cholesterol homeostasis genetic program, including Lxr and downstream transporters, Apoe, Abca1, and Abcg1 genes in vitro. Daidzein also elevated the cholesterol homeostasis genes in the poststroke brain with Apoe, the highest expressing transporter, but did not affect infarct volume or hemispheric swelling. Despite the absence of neuroprotection, daidzein improved motor/gait function in chronic stroke and elevated synaptophysin expression. However, the daidzein-enhanced functional benefits and synaptophysin expression were abolished in Apoe-knock-out mice, suggesting the importance of daidzein-induced ApoE upregulation in fostering stroke recovery. Dissociation between daidzein-induced functional benefits and the absence of neuroprotection further suggest the presence of nonoverlapping mechanisms underlying recovery processes versus acute pathology. With its known safety in humans, early and chronic use of daidzein aimed at augmenting ApoE may serve as a novel, translatable strategy to promote functional recovery in stroke patients without adverse acute effect.There have been recurring translational failures in treatment strategies for stroke. One underlying issue is the disparity in outcome analysis between animal and clinical studies. The former mainly depends on acute infarct size, whereas long-term functional recovery is an important outcome in patients. In an attempt to identify agents that promote functional recovery, we discovered that an FDA-approved soy isoflavone, daidzein, improved stroke-induced behavioral deficits via enhancing cholesterol homeostasis in chronic stroke, and this occurs without causing adverse effects in the acute phase. With its known safety in humans, the study suggests that the early and chronic use of daidzein serves as a potential strategy to promote functional recovery in stroke patients." @default.
• W2278884054 created "2016-06-24" @default.
• W2278884054 creator A5000747516 @default.
• W2278884054 creator A5004353870 @default.
• W2278884054 creator A5004992795 @default.
• W2278884054 creator A5014132243 @default.
• W2278884054 creator A5017687489 @default.
• W2278884054 creator A5022333584 @default.
• W2278884054 creator A5047765476 @default.
• W2278884054 creator A5058639895 @default.
• W2278884054 creator A5070365273 @default.
• W2278884054 creator A5076292863 @default.
• W2278884054 creator A5083481724 @default.
• W2278884054 date "2015-11-11" @default.
• W2278884054 modified "2023-10-17" @default.
• W2278884054 title "Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke" @default.
• W2278884054 cites W127683622 @default.
• W2278884054 cites W1877307747 @default.
• W2278884054 cites W1967539520 @default.
• W2278884054 cites W1976063550 @default.
• W2278884054 cites W1979226561 @default.
• W2278884054 cites W1985227899 @default.
• W2278884054 cites W1987432705 @default.
• W2278884054 cites W1991399891 @default.
• W2278884054 cites W1994456147 @default.
• W2278884054 cites W2006003725 @default.
• W2278884054 cites W2010058748 @default.
• W2278884054 cites W2023889117 @default.
• W2278884054 cites W2024679015 @default.
• W2278884054 cites W2024790024 @default.
• W2278884054 cites W2025831138 @default.
• W2278884054 cites W2026587556 @default.
• W2278884054 cites W2028627495 @default.
• W2278884054 cites W2043610521 @default.
• W2278884054 cites W2043805010 @default.
• W2278884054 cites W2046609531 @default.
• W2278884054 cites W2047397116 @default.
• W2278884054 cites W2049505964 @default.
• W2278884054 cites W2052853413 @default.
• W2278884054 cites W2053776819 @default.
• W2278884054 cites W2053815300 @default.
• W2278884054 cites W2054099490 @default.
• W2278884054 cites W2056571449 @default.
• W2278884054 cites W2058674940 @default.
• W2278884054 cites W2064672450 @default.
• W2278884054 cites W2069539036 @default.
• W2278884054 cites W2072302229 @default.
• W2278884054 cites W2072373049 @default.
• W2278884054 cites W2073411824 @default.
• W2278884054 cites W2073570862 @default.
• W2278884054 cites W2077078299 @default.
• W2278884054 cites W2081388499 @default.
• W2278884054 cites W2085374176 @default.
• W2278884054 cites W2093901484 @default.
• W2278884054 cites W2096597907 @default.
• W2278884054 cites W2099631417 @default.
• W2278884054 cites W2109968004 @default.
• W2278884054 cites W2112939466 @default.
• W2278884054 cites W2116824509 @default.
• W2278884054 cites W2118764299 @default.
• W2278884054 cites W2119343066 @default.
• W2278884054 cites W2121101037 @default.
• W2278884054 cites W2121146828 @default.
• W2278884054 cites W2122345275 @default.
• W2278884054 cites W2123111644 @default.
• W2278884054 cites W2125471921 @default.
• W2278884054 cites W2126328573 @default.
• W2278884054 cites W2145780739 @default.
• W2278884054 cites W2147330479 @default.
• W2278884054 cites W2151101257 @default.
• W2278884054 cites W2151194854 @default.
• W2278884054 cites W2157406373 @default.
• W2278884054 cites W2165373090 @default.
• W2278884054 cites W2166615294 @default.
• W2278884054 cites W2168130410 @default.
• W2278884054 cites W4240630814 @default.
• W2278884054 cites W4322703175 @default.
• W2278884054 doi "https://doi.org/10.1523/jneurosci.2890-15.2015" @default.
• W2278884054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4642242" @default.
• W2278884054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26558782" @default.
• W2278884054 hasPublicationYear "2015" @default.
• W2278884054 type Work @default.
• W2278884054 sameAs 2278884054 @default.
• W2278884054 citedByCount "39" @default.
• W2278884054 countsByYear W22788840542017 @default.
• W2278884054 countsByYear W22788840542018 @default.
• W2278884054 countsByYear W22788840542019 @default.
• W2278884054 countsByYear W22788840542020 @default.
• W2278884054 countsByYear W22788840542021 @default.
• W2278884054 countsByYear W22788840542022 @default.
• W2278884054 countsByYear W22788840542023 @default.
• W2278884054 crossrefType "journal-article" @default.
• W2278884054 hasAuthorship W2278884054A5000747516 @default.
• W2278884054 hasAuthorship W2278884054A5004353870 @default.
• W2278884054 hasAuthorship W2278884054A5004992795 @default.
• W2278884054 hasAuthorship W2278884054A5014132243 @default.
• W2278884054 hasAuthorship W2278884054A5017687489 @default.
• W2278884054 hasAuthorship W2278884054A5022333584 @default.

• next